Identification of the Major Immunogenic Structural Proteins of Human Foamy Virus

References

1. Achong B. G., Mansell P. W., Epstein M. A., Clifford P. 1971; An unusual virus in cultures from a human nasopharyngeal carcinoma. Journal of the National Cancer Institute 46:299–307
   [Google Scholar]
2. Allan J. S., Coligan J. E., Barin F., Mclane M. F., Sodroski J. G., Rosen C. A., Haseltine W. A., Lee T. Ft., Essex M. 1985; Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228:1091–1094
   [Google Scholar]
3. Benzair A.-B., Rhodes-Feuillette A., Lasneret J., Emanoil-Ravier R., Périès J. 1985; Purification and characterization of the major envelope glycoprotein of simian foamy virus type 1. Journal of Genera! Virology 66:1449–1455
   [Google Scholar]
4. Bigner D. D., Bigner H. S., Ponten J., Westermark B., Mahaley M. S., Ruoslathi E., Herschman H., Eng L. F., Wikstrand C. J. 1981; Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. Journal of Neuropathology and Experimental Neurology 40:201–229
   [Google Scholar]
5. Cameron K. R., Birchall S. M., Moses M. A. 1978; Isolation of foamy virus from a patient with dialysis encephalopathy. Lancet ii:796
   [Google Scholar]
6. Cavalieri F., Rhodes-Feuillette A., Benzair A.-B., Emanoil-Ravicovich R., Périès J. 1981; Biochemical characterization of simian foamy virus type 1. Archives of Virology 68:197–202
   [Google Scholar]
7. Enders J., Peebles T. 1954; Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proceedings of the Society for Experimental Biology and Medicine 86:277–287
   [Google Scholar]
8. Flügel R. M., Rethwilm A., Maurer B., Darai G. 1987; Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO Journal 6:2077–2084
   [Google Scholar]
9. Harlow E., Lane D. 1988; Immunoprecipitation. In Antibodies: A Laboratory Manual pp 421–470 New York: Cold Spring Harbor Laboratory.;
   [Google Scholar]
10. Hooks J. J., Detrick-HOOKS B. 1981; Spumavirinae: Foamy virus group infections: comparative aspects and diagnosis. In Comparative Diagnosis of Viral Diseases, 4 pp 599–618 Kurstak E., Kurstak C. Edited by New York: Academic Press;
    [Google Scholar]
11. Lee T. H., Coligan J. E., Homma T., Mclane M. F., Tachibana N., Essex M. 1984; Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. Proceedings of the National Academy of Sciences U.S.A: 813856–3860
    [Google Scholar]
12. Loh P. C., Matsuura F., Mizumoto C. 1980; Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific. Intervirology 13:87–90
    [Google Scholar]
13. Maurer B., Flügel R. M. 1988; Genomic organization of the human spuma retrovirus and its relatedness to AIDS and other retroviruses. AIDS Research and Human Retroviruses 4:467–473
    [Google Scholar]
14. Maurer B., Bannert H., Darai G., Flügel R. M. 1988; Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. Journal of Virology 62:1590–1597
    [Google Scholar]
15. Mergia A., Shaw K. E. S., Lackner J. E., Luciw P. A. 1990; Relationship of the env genes and the endonuclease domain of the pot genes of simian foamy virus type 1 and human foamy virus. Journal of Virology 64:406–410
    [Google Scholar]
16. Montagnier L., Clavel F., Krust B., Chamaret S., Rey F., Barré-Sinoussi F., Chermann J. C. 1985; Identification and antigenicity of the major envelope glycoprotein of lymphadeno- pathy-associated virus. Virology 144:283–289
    [Google Scholar]
17. Muller H. K., Ball G., Epstein M. A., Achong B. G., Lenoir G., Levin A. 1980; The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. Journal of General Virology 47:399–406
    [Google Scholar]
18. Nemo G. J., Brown P. W., Gibbs C. J., Gajdusek D. C. 1978; Antigenic relationship of human foamy virus to simian foamy virus. Infection and Immunity 20:69–72
    [Google Scholar]
19. Neumann-Haefelin D., Rethwilm A., Bauer G., Gudat F., Zur Hausen H. 1983; Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Medical Microbiology and Immunology 172:75–86
    [Google Scholar]
20. Rethwilm A., Darai G., Rösen A., Maurer B., Flügel R. M. 1987; Molecular cloning of the genome of human spumaretrovirus. Gene 59:19–28
    [Google Scholar]
21. Stancek D., Gessnerova M. 1974; A viral agent isolated from a patient with subacute de Quervain type thyroiditis. Acta virologica 18:365
    [Google Scholar]
22. Tarentino A. L., Gomez C. M., Plummer T. H. 1985; Deglycosylation of asparagine-linked glycans by peptide: N-glycosi-dase F. Biochemistry 24:4665–4671
    [Google Scholar]
23. Teich N. 1982; Taxonomy of retroviruses. In RNA Tumor Viruses 1 pp 25–207 Weiss R., Teich N., Varmus H., Coffin J. Edited by New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
24. Werner J., Gelderblom H. 1979; Isolation of foamy virus from patients with de Quervain thyroiditis. Lancet ii:258–259
    [Google Scholar]
25. Young D., Samuels J., Clarke J. K. 1973; A foamy virus of possible human origin isolated in BHK-21 cells. Archiv für die gesamte Virusforschung 42:228–234
    [Google Scholar]